Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR

Microgenics Corporation

Fremont, CA, US

Microgenics Corporation appears in FDA device records in Fremont, CA. FDA records list 128 510(k) clearances between and , no PMA records and one registered establishment. As of , FDA records show 14 recalls for this company, and at least one establishment registration is current.

FDA records held for this company

510(k) clearances
128
PMA records
0
Recall records
14
Registered establishments
1

510(k) clearance history

Showing 50 of 128

FDA records hold 128 510(k) clearances for Microgenics Corporation between 1985 and 2024. The busiest year on record is 1994, with 28. The most recent is 2024, with 2.

Clearances by year, as a table
510(k) clearance decisions for Microgenics Corporation, by decision year
YearClearances
19851
19861
19872
19882
19894
19905
19915
19925
19932
199428
199513
19962
20002
20014
20021
20036
20045
20052
20062
20093
20101
201111
20122
20134
20151
20172
20184
20192
20211
20221
20232
20242
510(k) clearances on record, most recent first
K numberDeviceProduct codeDecisionDecision date
K243498Alinity c Benzodiazepines Reagent KitJXMSubstantially Equivalent
K240670DRI Ecstasy Plus AssayDKZSubstantially Equivalent
K231020Alinity c Tricyclic Antidepressants Reagent KitLFHSubstantially Equivalent
K231007CEDIA Heroin Metabolite (6-AM) AssayDJGSubstantially Equivalent
K213875DRI TM Tricyclics Serum Tox AssayLFHSubstantially Equivalent
K211973DRI Cocaine Metabolite AssayDIOSubstantially Equivalent
K192943CEDIA Heroin Metabolite (6-AM) assayDJGSubstantially Equivalent
K190968CEDIA Benzodiazepine AssayJXMSubstantially Equivalent
DEN180030QMS Plazomicin ImmunoassayQDRUnknown
K181499DRI Cocaine Metabolite AssayDIOSubstantially Equivalent
K173963DRI Benzodiazepine AssayJXMSubstantially Equivalent
K173195DRI Hydrocodone AssayDJGSubstantially Equivalent
K173183CEDIA Heroin Metabolite (6-AM) AssayDJGSubstantially Equivalent
K163101CEDIA Buprenorphine II Assay; CEDIA Buprenorphine II Calibrators; CEDIA Negative Calibrator II; CEDIA Buprenorphine II Control SetDJGSubstantially Equivalent
K150502DRI Hydrocodone Assay, DRI Hydrocodone Calibrators, DRI Hydrocodone ControlsDJGSubstantially Equivalent
K122766THERMO SCIENTIFIC QMS EVEROLIMUS ASSAYOUFSubstantially Equivalent
K123343THERMO SCIENTIFIC QMS TACROLIMUS ASSAY AND CALIBRATORSMLMSubstantially Equivalent
K123518ABBOTT CARBAMAZEPINE ASSAYKLTSubstantially Equivalent
K123271ABBOTT PHENOBARBITAL ASSAYDLZSubstantially Equivalent
K120936ABBOTT TDM MULTICONSTITUENT CALIBRATOR, THERMO SCIENTIFIC QMS MULTI-CONSTITUENT CALIBRATORSDKBSubstantially Equivalent
K122291THERMO SCIENTIFIC MAS OMNI-CARDIOJJYSubstantially Equivalent
K110738THERMO SCIENTIFIC MAS OMNI-COREJJYSubstantially Equivalent
K110616THERMO SCIENTIFIC MAS OMNI-IMMUNE, MAS OMNI IMMUNE PROJJYSubstantially Equivalent
K101754THERMO SCIENTIFIC CEDIA OPIATE OFT ASSAYDJGSubstantially Equivalent
K101753THERMO SCIENTIFIC CEDIA METHAMPHETAMINE OFT ASSAYLAFSubstantially Equivalent
K101752THERMO SCIENTIFIC CEDIA MULTI-DRUG OFT CALIBRATORSDKBSubstantially Equivalent
K101746THERMO SCIENTIFIC CEDIA PHENCYCLIDINE (PCP) OFT ASSAYLCMSubstantially Equivalent
K101745THERMO SCIENTIFIC CEDIA AMPHETAMINE OFT ASSAYDKZSubstantially Equivalent
K101744THERMO SCIENTIFIC CEDIA CANNABINOIDS OFT ASSAYLDJSubstantially Equivalent
K101742THERMO SCIENTIFIC CEDIA COCAINE OFT ASSAYDIOSubstantially Equivalent
K103656THERMO SCIENTIFIC MAS R DOA TOTALDIFSubstantially Equivalent
K100144THERMO SCIENTIFIC QMS EVEROLIMUS REAGENTS, CALIBRATORS AND CONTROLSOUFSubstantially Equivalent
K093114THERMO SCIENTIFIC DRI AMPHETAMINES ASSAYDKZSubstantially Equivalent
K092749MAS AND MINI-TROL PTH CONTROLJJXSubstantially Equivalent
K092051THERMO SCIENTIFIC MAS CHEM TRAK & MONI TROL H LIQUID ASSAYED CHEMISTRY CONTROL, MODEL, CHA, CHU, M5155, M5158JJYSubstantially Equivalent
K090810THERMO SCIENTIFIC CYTO-CAL COUNT TUBESGKZSubstantially Equivalent
K061196CARDIOIMMUNE XL CARDIAC MARKER CONTROLJJYSubstantially Equivalent
K053411DRI HEMOGLOBIN A1C ASSAY AND CALIBRATORSLCPSubstantially Equivalent
K051074MAS IMMUNOSUPPRESSANT CONTROLSLASSubstantially Equivalent
K050206CEDIA TACROLIMUS ASSAYMLMSubstantially Equivalent
DEN040008CEDIA SIROLIMUS ASSAYNRPUnknown
K040316CEDIA BUPRENORPHINE ASSAYDJGSubstantially Equivalent
K040758MGC DAU CONTROL SETS: PRIMARY, CLINICAL AND SELECTDIFSubstantially Equivalent
K040411DRI OXYCODONE ASSAYLASSubstantially Equivalent
K041073DOCUMENT SALICYLATE CAL VERJJYSubstantially Equivalent
K032811CEDIA VANCOMYCIN ASSAYLEHSubstantially Equivalent
K032842MICROGENICS CYCLOSPORINE CONTROL KITLASSubstantially Equivalent
K023617DRI METHADONE METABOLITE ENZYME IMMUNOASSAYDJRSubstantially Equivalent
K030649DRI COTININE EIA ASSAYMRSSubstantially Equivalent
K030616CEDIA CYCLOSPORINE PLUS HIGH RANGE CONTROLS 4 AND 5LASSubstantially Equivalent

Registered establishments

FDA registered establishments for Microgenics Corporation, with the product codes listed at each
RegistrationFEIEstablishmentAddressRegistration expiresProduct codes listed
30109398973010939897Microgenics Corporation46500 Kato Road, Fremont, CA 94538 US2026and 57 more, listed in full below

Registration numbers link to the FDA registration and listing record for that establishment.

FDA product codes

Recall records

Device recall records naming this company, most recent first
RecallProductReasonClassificationInitiatedStatus
Z-0415-2026Thermo scientific MAS Omni CARDIO, Liquid Assayed Integrated Cardiac Control, Model/Catalog Number: OCRD-L, OCRD-101, OCRD-202, OCRD-303, OCRD-SP, OCRD-MP, OCRD-UL; Product Description: In Vitro Diagnostic external controlThe firm received complaints from customers reporting vial-to-vial variability when using the control with high sensitivity Troponin I assays. This defect may lead to as delay in patient results for hs Troponin I assays.Class IIOpen, Classified
Z-1284-2022QMS Tacrolimus Immunoassay REF 10015573 CALIBRATOR SET QMS TACROLIMUS CAL A 10015566-3 QMS TACROLIMUS CAL B 10015567-3 QMS TACROLIMUS CAL C 10015568-3 QMS TACROLIMUS CAL D 10015569-3 QMS TACROLIMUS CAL E 10015570-3 QMS TACROLIMUS CAL F 10015571-3Due to QMS Tacrolimus Calibrator recovering between 82 to 94% of their target values, resulting in over-quantitation in tacrolimus patient result values when used with the QMS Tacrolimus Immunoassay.Class IIOpen, Classified
Z-0008-2017Thermo Scientific QMS Everolimus Assay; Model number: 0380000 (US Distribution); 0373852 (Foreign Distribution) Product Usage: The QMS Everolimus Assay is intended for the quantitative determination of Everolimus, in human whole blood on automated clinical chemistry analyzers. The results obtained are used as an aid in the management of kidney and liver transplant patients receiving Everolimus therapy. This in vitro diagnostic device is intended for clinical laboratory use only. The QMS Everolimus assay is intended to be used as an aid in the management of patients receiving everolimus therapy for those organ transplant procedures indicated in the chart for each specific country.A reagent stability issue (still under investigation) causes less separation in the calibration curve, which affects results across the entire range. For controls, maximum bias of +/- 35% for low levels, +/- 33% for mid-range levels, and +/- 47% for high levels is observed. Bias in patient samples ranges from -15.7% to +5.2% with an average bias of -5.6% when comparing the QMS everolimus assay to an everolimus LC-MS reference method. Patient samples across the measuring range sub-therapeutic, therapeutic, and supra-therapeutic could be affected.Class IITerminated
Z-2884-2016DRI Salicylate Serum Tox Assay, Catalog number 0977. Toxicology: The DRI Salicylate Serum Tox Assay is intended for the quantitative determination of salicylate in human serum or plasma.Some lots of DRI Salicylate Serum Tox Assay negative patient samples are recovering higher than the product sensitivity claim of 4.4 mg/dL.Class IITerminated
Z-0501-2015MAS CardioImmune XL Cardiac Marker Control; Model: CAI-XL1; intended for use in the clinical laboratory as an assayed control serum for monitoring assay conditions in specific cardiac marker determinations.MAS CardioImmune XL, level 1 (lot CXL16011), is showing vial-to-vial variation for the analytes Creatine Kinase-MB (CK-MB) and B-Type Natriuretic Peptide-32 (BNP-32).Class IITerminated
Z-1930-2014MAS Omni Immune PRO ControlsThe constituent, Inhibin A, was removed from MAS Omni IMMUNE and MAS Omni IMMUNE PRO controls; however the package insert was not updated to reflect the change.Class IIITerminated
Z-1929-2014MAS Omni Immune ControlsThe constituent, Inhibin A, was removed from MAS Omni IMMUNE and MAS Omni IMMUNE PRO controls; however the package insert was not updated to reflect the change.Class IIITerminated
Z-0513-2014Thermo Fisher Scientific/Microgenics brand CEDIA Tobramycin II Assay, Catalog Number 100018, Product is manufactured and distributed by Microgenics Corporation, located at Fremont, CA., part of Thermo Fisher Scientific The CEDIA Tobramycin II Assay is an in vitro diagnostic medical device intended for the quantitation of Tobramycin in human serum or plasma.Microgenics Corp., part of Thermo Fisher Scientific, is recalling CEDIA Tobramycin II Assay (Lot Number: 60169764) due to calibration stability problem relating to two complaints received.Class IITerminated
Z-2267-2013DRI Cocaine Metabolite Assay, labeled as Multigent Cocaine Assay for Abbott Laboratories. 100 ml, IVD Mfg by: Microgenics Corporation, 46360 Fremont Blvd. Fremont, CA 94538 The DRI Cocaine Metabolite Enzyme Immunoassay is a homogeneous enzyme intended for the qualitative and semi-quantitative determination of benzoylecgonine (Cocaine Metabolite) in human urine with either 300 ng/mL or 150 ng/mL as a cutoff calibrator. The assay provided only a preliminary analytical test result. A more specific alternative chemical method must be used to obtain a confirm analytical result.Surveillance of reagent stability for specific lots of DRI Cocaine Metabolite Reagent show an unexpected decreasing change in the reaction rate, indicating a faster than expected reagent degradation.Class IITerminated
Z-1563-2013Thermo Scientific MAS Bilirubin for Siemens and Dimension Vista Systems, , Product is manufactured and distributed by Microgenics Corporation, Fremont, CA MAS Bilirubin is intended for use as a consistent test sample of known concentration for monitoring assay conditions in many clinical laboratory determinations. Includes Bilirubin with patient serum specimens when assaying for any of the listed constituents. Assay values are provided for the specific systems listed. The user can compare observations with expected ranges as a means of assuring consistent performance of reagent and instrument.It has been confirmed from in-house testing that Direct Bilirubin (DBIL), and Total Bilirubin (TBIL) claimed in Thermo Scientific MAS Bilirubin Systems are displaying reduced stability.Class IITerminated
Z-0379-2013Thermo Scientific MAS Omni IMMUNE and Omni IMMUNE PRO; Liquid Assayed Integrated Immunoassay Control. Intended for use as an assayed control for monitoring assay conditions in many clinical laboratory determinations. Assay values are provided for the specific systems listed. The user can compare observations with expected ranges as a means of assuring consistent performance or reagent and instrument. .In house testing confirmed that CK-MS and Insulin claimed in both Omni IMMUNE and Omni IMMUNE PRO products are displaying reduced stability.Class IIITerminated
Z-0637-2012ThermoFisher Scientific / Microgenics brand MAS CardioImmune XL, Liquid Assayed Cardiac Marker Control, in vitro diagnostic. Catalog Numbers & Description: CAI-XLL, Level L; CAI-XL1, Level 1; CAI-XL2, Level 2; CAI-XL3, Level 3; CAI-XL4, Multi-Pack; CAI-XLS, Sample Pack;Low measurements of Troponin I in the MAS CardioImmune XL Control which were outside the published control ranges.Terminated
Z-0773-2012Tobramycin Calibrators, REF 7F93-01; Microgenics Corporation, 46360 Fremont Blvd Fremont, CA 94538; Distributed by Abbott Diagnostics, 100 Abbott Park Road, Abbott Park, Illinois 60064. .Tobramycin is a commonly used antibiotic to treat bacterial infections, in particular gram negative infections.Reports that third party control material for 4 lots of Tobramycin Calibrators that are recovering low and outside of the published range.Terminated
Z-0297-2012Multigent Vancomycin Calibrators; Manufactured by Microgenics Corp, Fremont, CA. Distributed by: Abbott Diagnostics, Abbott Park, IL Product Usage: The Multigent Vancomycin calibrators are intended for use in the calibration of the multiagent vancomycin Vancomycin is a commonly used antibiotic to treat staphylococcus and other gram-positive bacterial infections.Complaint from the sole distributor that the third party control material is recovering high, and outside the published range.Terminated

Verification record

There is no verification record for this company. Most companies on this site have none: a record exists only where a company asked to be verified and MDM ran the checks, so the absence of one says nothing about the company.

Where there is a record, this is where it appears: what was checked, when it was checked, and the current status. An MDM Verified badge on another website links to a verify address on this domain that resolves to this section. A badge that does not resolve here is not ours.

What MDM checks, and what it does not

MDM coverage

MDM coverage of this company lists here, newest first. Submit news.

Is this your company?

This page is built from public FDA records. Company pages are free and factual, and stay free whether or not anyone claims them. Membership never changes editorial coverage or vetting outcomes.

Claiming lets Microgenics Corporation edit what it says about itself and list the categories it works in. It grants no badge: claiming is not verification.

Claim this page

Data as of , FDA export datePage updated Source: openFDA, public domain